These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38103077)

  • 1. The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database.
    Jiang Y; Du Z; Shen Y; Zhou Q; Zhu H
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; ():. PubMed ID: 38103077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database.
    Liu R; Liu C; Feng D; Guo T; Wang Y
    Front Pharmacol; 2024; 15():1414703. PubMed ID: 38948465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
    Gastaldon C; Raschi E; Kane JM; Barbui C; Schoretsanitis G
    Psychother Psychosom; 2021; 90(1):41-48. PubMed ID: 32854103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of Brexpiprazole: Real-world adverse event analysis from the FAERS database.
    Jiang Y; Zhou L; Shen Y; Zhou Q; Ji Y; Zhu H
    J Affect Disord; 2024 Feb; 346():223-229. PubMed ID: 37956832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database.
    Ning L; Tian Y; Chen D; Han J; Xie G; Sun J
    Heliyon; 2024 Sep; 10(18):e37348. PubMed ID: 39309940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of post-market adverse events of istradefylline: a real-world study base on FAERS database.
    Jiang Y; Lu R; Zhou Q; Shen Y; Zhu H
    Sci Rep; 2024 Apr; 14(1):7659. PubMed ID: 38561511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database.
    Liu F; Zheng JX; Wu XD
    Front Pharmacol; 2024; 15():1365706. PubMed ID: 39015372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS).
    McIntyre RS; Mansur RB; Rosenblat JD; Teopiz KM; Kwan ATH
    Expert Opin Drug Saf; 2024 Jun; ():1-6. PubMed ID: 38884147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining and analysis of adverse event signals of Cariprazine based on the real-world data of FAERS database.
    Zhu H; Qu Y; Du Z; Zhou Q; Shen Y; Jiang Y; Zhou Z; Zhou H
    J Affect Disord; 2024 Feb; 347():45-50. PubMed ID: 37992768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the adverse effects of ketamine and esketamine between genders using FAERS data.
    Yang X; Chen D
    Front Pharmacol; 2024; 15():1329436. PubMed ID: 39070784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database.
    Chen S; Fang W; Zhao L; Xu H
    Front Pharmacol; 2024; 15():1369384. PubMed ID: 38560357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
    Cui Z; Cheng F; Wang L; Zou F; Pan R; Tian Y; Zhang X; She J; Zhang Y; Yang X
    Front Pharmacol; 2023; 14():1259908. PubMed ID: 37954852
    [No Abstract]   [Full Text] [Related]  

  • 13. Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database.
    Lu R; Jiang Y; Du Z; Zhou Q; Shen Y; Zhu H
    J Affect Disord; 2024 Jun; 354():649-655. PubMed ID: 38494134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database.
    Yang H; Wan Z; Chen M; Zhang X; Cui W; Zhao B
    Expert Opin Drug Metab Toxicol; 2023 Apr; 19(4):217-223. PubMed ID: 37243615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database.
    Liu W; Du Q; Guo Z; Ye X; Liu J
    Front Pharmacol; 2023; 14():1283247. PubMed ID: 38027003
    [No Abstract]   [Full Text] [Related]  

  • 16. Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States.
    Zhdanava M; Teeple A; Pilon D; Shah A; Caron-Lapointe G; Joshi K
    J Med Econ; 2023; 26(1):691-700. PubMed ID: 37130075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database.
    Zhao B; Zhang X; Chen M; Wang Y
    Expert Opin Drug Metab Toxicol; 2023; 19(6):381-387. PubMed ID: 37421631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS.
    Tang S; Wu Z; Xu L; Wen Q; Zhang X
    Front Pharmacol; 2022; 13():970066. PubMed ID: 36263117
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.
    Wei W; Chen L; Zhou H; Liu J; Zhang Y; Feng S; Bai Y; Leng Y; Chang E; Huang L
    Front Pharmacol; 2023; 14():1208456. PubMed ID: 37645441
    [No Abstract]   [Full Text] [Related]  

  • 20. A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).
    Shi X; Cheng Q; Zhao YZ; Zou SP; Sun MH
    Osteoporos Int; 2023 Dec; 34(12):2047-2058. PubMed ID: 37594595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.